Archive for the ‘Department of Health and Human Services’ Category
CEO took roundabout path to Emergent
By Marjorie Censer
Monday, January 3, 2011
Fuad El-Hibri has lived in all sorts of exotic locales, working for Citicorp in Saudi Arabia, consulting for Booz Allen Hamilton in Indonesia and establishing mobile telecommunications businesses in Russia, Venezuela and El Salvador.
But getting started in his current position as chief executive of Rockville-based pharmaceutical company Emergent BioSolutions took [...]
January 7, 2011
Tags: Chief executive officer, Department of Health and Human Services, El-Hibri, Emergent BioSolutions Inc., entrepreneur, Rockville Posted in: Biosolutions, Business, CEO, Department of Health and Human Services, El-Hibri, Emergent BioSolutions, Research and development, Trubion Pharmaceuticals, Yale University, fuad, fuad el-hibri 
No Comments
Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland
ROCKVILLE, MD, May 13, 2010 – Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has been named Biotechnology Firm of the Year at the Tech Council of Maryland’s (TCM) Annual Tech Awards. This award acknowledges the company that best exemplifies the spirit of Maryland’s biotechnology community as well as its presence and leadership within the [...]
May 18, 2010
Tags: Business, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, fuad el-hibri, Research and development, Tech Council of Maryland Posted in: CEO, Department of Health and Human Services, Emergent BioSolutions, Research and development, Tech Council of Maryland, fuad el-hibri No Comments
Fuad el-Hibri, king of anthrax, wins an award from Ernst & Young
Marie-José Daoud
Awarded the Ernst and Young prize for Entrepreneur of the year 2009 in the Technology category for the Greater Washington region last June, Fuad El-Hibri is the CEO of Emergent Biosolutions, an American company that supplies the anthrax vaccine to the American government. He is in line for the national E&Y 2009 prize, which [...]
December 17, 2009
Tags: Emergent BioSolutions, Ernst & Young, Federal government of the United States, Food and Drug Administration, Porton Product, United States. Posted in: Biosolutions, Department of Health and Human Services, El-Hibri, Emergent BioSolutions, fuad el-hibri No Comments
Emergent BioSolutions reacts to BARDA’s Request for Proposal cancellation
by Nick Rees on December 8, 2009
Fuad El-Hibri
The Office of the Biomedical Advanced Research and Development Authority has advised Emergent BioSolutions that while BARDA’s Request for Proposal has been canceled, Emergent is encouraged to submit a proposal for the office’s Broad Agency Announcement.
BARDA canceled the RFP for the procurement for rPA vaccines after [...]
December 15, 2009
Tags: Biomedical Advanced Research and Development Authority, Centers for Disease Control and Prevention, Chief executive officer, Emergent BioSolutions, Federal government of the United States, fuad el-hibri, Strategic National Stockpile, United States. Posted in: BARDA, Biosolutions, CEO, Department of Health and Human Services, Emergent BioSolutions, Maryland, fuad el-hibri No Comments
Bad News Clouds Two Bio Defense Stocks
Written by Staff and Wire Reports
Tuesday, 08 December 2009 01:28
Key news developments will affect shares of these two companies who help meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons.
The two companies which waited until late after hours on Monday to announce [...]
December 15, 2009
Tags: Centers for Disease Control and Prevention, fuad el-hibri, Project Bioshield Act, Strategic National Stockpile, United States Department of Health and Human Services, United States. Posted in: BARDA, Department of Health and Human Services, El-Hibri, Emergent BioSolutions, Management, biotechnology, fuad el-hibri No Comments